Publications by authors named "C Cormack Gates"
Small cell lung cancer (SCLC) is an aggressive form of neuroendocrine neoplasm known for its striking initial response to treatment, followed by fast relapse and refractoriness in response to additional lines of therapy. New advances in immunotherapy are paving the way for more effective treatment strategies and have promising results with early clinical trial data. While SCLC rarely harbors actionable mutations, the receptor DLL3 is extensively present in SCLC, making it a potential target for immunotherapy.
View Article and Find Full Text PDFBackground: Optimal secondary prevention antithrombotic therapy for patients with antiphospholipid syndrome (APS)-associated ischemic stroke, transient ischemic attack, or other ischemic brain injury is undefined. The standard of care, warfarin or other vitamin K antagonists at standard or high intensity (international normalized ratio (INR) target range 2.0-3.
View Article and Find Full Text PDFArticle Synopsis
- Mesenchymal stem cells (MSCs) are special cells that scientists think can help with bone and joint problems in medicine, especially in orthopaedics.
- This study looked at many different research papers to see how well these MSCs work and if they are safe for patients with different bone and joint issues.
- The results showed that using MSCs helped improve conditions like arthritis and certain bone injuries in many patients, which is a positive sign for their future use in treating these problems.